Analytical Data
-
Gene name
WFDC6
- Application
-
Alternative Names
WFDC6; C20orf171; WAP6; WAP four-disulfide core domain Protein 6; Putative protease inhibitor WAP6
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BQY6
-
Expression Region
26-131 aa
-
AA Sequence
EGILG KPCPKIKVEC EVEEIDQCTK PRDCPENMKC CPFSRGKKCL DFRKIYAVCH RRLAPAWPPY HTGGTIKKTK ICSEFIYGGS QGNNNNFQTE AICLVTCKKY H
-
Molecular Weight
14.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
WFDC6, or WAP four-disulfide core domain 6, is a cysteine-rich protein that belongs to the WFDC (WAP-type four-disulfide core) family, which is known for its role in various biological processes, including immune response, reproductive functions, and epithelial cell protection. Given its unique structural features and potential regulatory roles within the extracellular environment, WFDC6 has gained attention in biomedical research, particularly in the context of cancer biology and inflammatory diseases. Studies have indicated that WFDC6 may influence tumor progression and metastasis, as its expression levels can vary significantly in different cancer types. Furthermore, its interaction with other proteins and involvement in extracellular matrix modulation suggests that WFDC6 could be a key player in cell signaling and matrix remodeling.
Researchers are now exploring the potential therapeutic applications of WFDC6, including its use as a biomarker for early cancer detection and as a target for novel drug development. The production of recombinant WFDC6 protein has facilitated studies on its functional properties and interactions, enhancing our understanding of its role in health and disease. Continued investigation into WFDC6 promises to uncover important insights into its physiological significance and potential contributions to therapeutic strategies, particularly in oncology and regenerative medicine. This multifaceted protein represents a promising avenue for future research aimed at unraveling its complex biological roles and clinical applications.
